CLINICAL_TRIALS
trial_result
· 2013-12-30
Clinical Trial Update: Velcade Consolidation Bone Study [Phase 2]
Summary
Phase 2 Velcade (bortezomib) consolidation study for bone involvement in multiple myeloma has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen-Cilag International NV | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-30